TLX compared with BZAI: revenue, margins and what each company keeps, and the suppliers and customers both name

TLXTelix Pharmaceuticals Ltd

Mkt capRevenueRevenue

BZAIBlaize Holdings, Inc.

Mkt capRevenueRevenue

Compare

TLXTelix Pharmaceuticals Ltd

BZAIBlaize Holdings, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TLX: latest quarter not drawable. BZAI: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

TLX, solidBZAI, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TLX 1

LLYEli Lillycustomer

Shared 0

No shared counterparties.

Only BZAI 9

—Customer Dunlistedcustomer

—Undisclosed major customer in Chinaunlistedcustomer

—Customer Cunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Plexus

unlistedsupplier

5 more · BZAI chain ›

TLXTelix Pharmaceuticals Ltd

9.10▼−4.28%· post 9.09

Mkt cap$3.1BRevenue—Revenue—

BZAIBlaize Holdings, Inc.

0.20▼−0.40%· post 0.20

ClosedOct 30 '26

Mkt cap$28.3MRevenue$12MQ2 FY26Revenue$39MFY25

Compare

ClosedOct 30 '26

TLXTelix Pharmaceuticals Ltd

BZAIBlaize Holdings, Inc.

9.10▼−4.28%post 9.09

Price

0.20▼−0.40%post 0.20

$3.1B

Mkt cap

$28.3M

—

Revenue

$12MQ2 FY26

—

Revenue

$39MFY25

TLX9.10▼−4.28%vsBZAI0.20▼−0.40%ClosedOct 30 '26